Triple Therapy Effective for Severe COPD Exacerbations
(MedPage Today) -- Treatment with once-daily single-inhaler fluticasone furoate/umeclidinium/vilanterol (Trelegy Ellipta) triple therapy appears to be more efficacious in reducing severe exacerbations in patients with chronic obstructive pulmonary...
Read more »